AUG 17, 2020 8:44 AM PDT

Are Cancer Exosomes a Good Source of Biomarkers?

WRITTEN BY: Jasper Cantrell

One of cancer’s most aggravating qualities is its ability to control the microenvironment around it. This control can make cancer treatment even more of a headache, whether it’s suppressing the immune response or promoting aggressive behavior.

A team from the University of Ottawa in Canada wanted to investigate an aspect of this control, specifically exosomes and their diagnostic value. An exosome is small lipid “package” that can hold and protect proteins and other signaling molecules until it contacts another cell. It then “delivers” its contents into the cell. In the case of cancer, these exosomes carry signals to nearby cells that can promote cancer transformation or even immunosuppression.

Many studies have pointed out the diagnostic potential of exosomes for cancer. They could be isolated from a blood sample and tested for any cancer biomarkers. This new study sought to identify membrane-bound markers specifically, as they would be easier to test. They started with a healthy cell line and a breast cancer cell line and developed a protocol for exosome extraction.

The protocol they used had three steps: isolation of exosomes, the breakup of exosomes with detergent, and analysis by mass spectrometry. Mass spectrometry is a well-trusted method of identifying proteins and molecules in a sample, and the other three steps were optimized to provide the most proteins per exosome purified.

Initial readings showed exosomes from a breast cancer cell line had over 700 unique proteins compared to exosomes from a normal cell line. Most of these were involved in cellular signaling and motility. Further analysis narrowed down the 700 unique proteins to 247 cancer-related proteins, then to 87 breast cancer-related proteins, and then down to 8 membrane-bound biomarker candidates. A final in-depth literature review found 3 of these had the highest potential: GPC-1, GLUT-1, and ADAM10.

All three proteins are established to be associated with late-stage or aggressive breast cancer, and validation tests showed that each candidate could be identified relatively easily. They also note that while all three have potential as biomarkers, retrieving cancer-specific exosomes can be challenging. A new method would likely have to be developed for that purpose.

The study concludes, “In this study, we demonstrate the richness of the metastatic breast cancer cell line-derived exosomes in relevant proteins capable of driving cancer metastasis.” and “Our findings justify the further study of exosomes for BC biomarker discovery.”

Sources: Nature Scientific Reports, The Novus Center

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
NOV 09, 2020
Cancer
A Prognostic Expression Profile for Osteosarcoma
NOV 09, 2020
A Prognostic Expression Profile for Osteosarcoma
Tireless research goes into every cancer diagnostic tools and new therapy. Many types of cancer have made giant steps fo ...
NOV 26, 2020
Clinical & Molecular DX
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
NOV 26, 2020
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
New research has revealed that exposure to radiation from diagnostic procedures such as X-rays could contribute to an el ...
NOV 21, 2020
Cancer
Hospital patients want processed meats removed from hospital menus
NOV 21, 2020
Hospital patients want processed meats removed from hospital menus
A survey published in the Journal of Hospital Management and Health Policy reports that most patients are in agreem ...
DEC 21, 2020
Cancer
Examining the Bioactive Components of an Alga Against Cancer
DEC 21, 2020
Examining the Bioactive Components of an Alga Against Cancer
Many of today’s drugs come from vast libraries of synthetic compounds built by chemists for big pharma. This drug ...
DEC 24, 2020
Genetics & Genomics
After Chromosomes Shatter, Cancer Cells Can Become Drug-Resistant
DEC 24, 2020
After Chromosomes Shatter, Cancer Cells Can Become Drug-Resistant
Many types of cells have to be replenished throughout our lives, and cells divide to replace those that are damaged or w ...
JAN 14, 2021
Clinical & Molecular DX
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
JAN 14, 2021
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
  Only 10 percent of icebergs are visible on the surface of the water; the remaining 90 percent remains submerged. ...
Loading Comments...